I
IX Biopharma Ltd
SGX:42C
IX Biopharma Ltd
SGX:42C
Price:
0.039 SGD
-9.3%
Market Closed
Updated:
May 19, 2024
IX Biopharma Ltd
Selling, General & Administrative
|
IX Biopharma Ltd
Selling, General & Administrative Peer Comparison
Comparables:
WVE
H02
H
1J5
Competitive Selling, General & Administrative Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Selling, General & Administrative | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
I
|
IX Biopharma Ltd
SGX:42C
|
Selling, General & Administrative
-S$7.5m
|
CAGR 3-Years
5%
|
CAGR 5-Years
1%
|
CAGR 10-Years
N/A
|
|
|
WAVE Life Sciences Ltd
NASDAQ:WVE
|
Selling, General & Administrative
-$52.6m
|
CAGR 3-Years
-10%
|
CAGR 5-Years
-4%
|
CAGR 10-Years
N/A
|
|
|
Haw Par Corporation Ltd
SGX:H02
|
Selling, General & Administrative
-S$70.9m
|
CAGR 3-Years
-27%
|
CAGR 5-Years
-3%
|
CAGR 10-Years
-5%
|
|
H
|
Hyphens Pharma International Ltd
SGX:1J5
|
Selling, General & Administrative
-S$49.6m
|
CAGR 3-Years
-11%
|
CAGR 5-Years
-9%
|
CAGR 10-Years
N/A
|
See Also
What is IX Biopharma Ltd's Selling, General & Administrative?
Selling, General & Administrative
-7.5m
SGD
-7.5m
SGD
Based on the financial report for Dec 31, 2023, IX Biopharma Ltd's Selling, General & Administrative amounts to -7.5m SGD.
What is IX Biopharma Ltd's Selling, General & Administrative growth rate?
Selling, General & Administrative CAGR 5Y
1%
1%
Over the last year, the Selling, General & Administrative growth was 13%. The average annual Selling, General & Administrative growth rates for IX Biopharma Ltd have been 5% over the past three years , 1% over the past five years .
You don't have any saved screeners yet
